Altimmune, Inc.
ALT$327M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaGAITHERSBURG
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Aug 11, 2026
7wMarket Overview
Stock performance and key metrics
ALT News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ALT-801 | Phase 2 | Obesity/Overweight | - | - |
Pemvidutide | Phase 2 | Alcohol Use Disorder (AUD) | - | - |
NasoVAX | Phase 2 | Influenza | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply